AtriCure (ATRC) Accumulated Expenses (2010 - 2026)

AtriCure (ATRC) has reported Accumulated Expenses for 17 consecutive years, with $42.9 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Accumulated Expenses rose 6.55% year-over-year to $42.9 million; the TTM figure through Jun 2026 stood at $42.9 million (up 6.55% YoY), while the FY2025 annual figure was $53.1 million, up 16.46% from the prior year.
• Accumulated Expenses climbed to $42.9 million in Q2 2026 per ATRC's latest filing, from $39.5 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $53.1 million in Q4 2025 and bottomed at $25.3 million in Q1 2022.
• Historically, Accumulated Expenses has averaged $37.1 million across 5 years, with a median of $35.2 million in 2023.
• Annual changes were most pronounced in 2022 — Accumulated Expenses slipped 14.73% — and 2023, when it surged 35.31%.
• AtriCure's Accumulated Expenses stood at $33.0 million in 2022, then surged by 35.31% to $44.7 million in 2023, then increased by 2.03% to $45.6 million in 2024, then climbed by 16.46% to $53.1 million in 2025, then slipped by 19.21% to $42.9 million in 2026.
• Business Quant data shows ATRC's Accumulated Expenses at $42.9 million in Q2 2026, $39.5 million in Q1 2026, and $53.1 million in Q4 2025.